The Impact of Irrisept in Reducing Urinary Tract Infection During Urethral Catheter Removal.
Recruiting now · Not applicable
Conditions studied: Urinary Tract Infection, Antibiotic, Catheter Infection
In brief
Given the high burden of post-catheter removal UTIs, this study aims to evaluate Irrisept instillation as a non-antibiotic intervention to reduce infection rates. By comparing Irrisept to saline irrigation, the study will provide critical insights into the efficacy of antiseptic bladder irrigation in preventing UTIs while minimizing antibiotic use. If successful, this approach could lead to new clinical guidelines for catheter removal protocols, improving patient outcomes and reducing healthcare costs.
Key facts
- Study ID
- NCT07239219
- Run by
- Ohio State University
- People needed
- 300
- Starts
- 2026-01-01
- Expected to finish
- 2028-01-01
- Last updated by the study team
- 2026-07-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Presenting to the urology clinic for catheter removal
- Must be 18 years or older.
- The patient must be able to understand and willing to provide informed consent as described in this study protocol.
- Must be willing to complete a post-catheter removal survey
You may not qualify if…
- Allergy or adverse reaction to chlorohexidine gluconate
- Under the age of 18
- Refuse to provide informed consent
- On antibiotic therapy for any indication.
- Women who are pregnant or breastfeeding
- Signs of skin or systemic infection
- Patients undergoing catheter exchange
Where it is running
- The Ohio State University — Columbus, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.